Authors:
Harris, ST
Eriksen, EF
Davidson, M
Ettinger, MP
Moffett, AH
Baylink, DJ
Crusan, CE
Chines, AA
Citation: St. Harris et al., Effect of combined risedronate and hormone replacement therapies on bone mineral density in postmenopausal women, J CLIN END, 86(5), 2001, pp. 1890-1897
Authors:
Miller, PD
Woodson, G
Licata, AA
Ettinger, MP
Mako, B
Smith, ME
Wang, LX
Yates, J
Melton, ME
Palmisano, JJ
Citation: Pd. Miller et al., Rechallenge of patients who had discontinued alendronate therapy because of upper gastrointestinal symptoms, CLIN THER, 22(12), 2000, pp. 1433-1442
Authors:
Rittmaster, RS
Bolognese, M
Ettinger, MP
Hanley, DA
Hodsman, AB
Kendler, DL
Rosen, CJ
Citation: Rs. Rittmaster et al., Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate, J CLIN END, 85(6), 2000, pp. 2129-2134
Authors:
Downs, RW
Bell, NH
Ettinger, MP
Walsh, BW
Favus, MJ
Mako, B
Wang, LX
Smith, ME
Gormley, GJ
Melton, ME
Citation: Rw. Downs et al., Comparison of alendronate and intranasal calcitonin for treatment of osteoporosis in postmenopausal women, J CLIN END, 85(5), 2000, pp. 1783-1788